Ticker >

Metropolis Health. share price

Metropolis Healthcare Ltd.

NSE: METROPOLIS BSE: 542650 SECTOR: Hospital & Healthcare Services  120k   548   51

1902.75
+62.15 (3.38%)
NSE: Today, 04:06 PM

Price Summary

Today's High

₹ 1915

Today's Low

₹ 1825.3

52 Week High

₹ 1933.5

52 Week Low

₹ 1239

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9747.56 Cr.

Enterprise Value

9786.91 Cr.

No. of Shares

5.12 Cr.

P/E

78.58

P/B

9.57

Face Value

₹ 2

Div. Yield

0.42 %

Book Value (TTM)

₹  198.9

CASH

42.94 Cr.

DEBT

82.29 Cr.

Promoter Holding

49.67 %

EPS (TTM)

₹  24.21

Sales Growth

-7.86%

ROE

15.82 %

ROCE

19.87%

Profit Growth

-30.36 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-7.86%
3 Year17.02%
5 Year17.06%

Profit Growth

1 Year-30.36%
3 Year7.43%
5 Year7.73%

ROE%

1 Year15.82%
3 Year24.68%
5 Year24.9%

ROCE %

1 Year19.87%
3 Year32.17%
5 Year33.31%

Debt/Equity

0.0886

Price to Cash Flow

41

Interest Cover Ratio

6.71830481826839

CFO/PAT (5 Yr. Avg.)

1.2666907689912

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 49.67 1.18
Dec 2023 49.74 1.18
Sep 2023 49.74 1.18
Jun 2023 49.75 1.18
Mar 2023 49.75 1.18
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 17.0172425671552% for the Past 3 years.
  • The company has significantly decreased its debt by 176.253 Cr.
  • Company has been maintaining healthy ROE of 24.678432907774% over the past 3 years.
  • Company has been maintaining healthy ROCE of 32.1727366508857% over the past 3 years.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 26.992132202242% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -78.6593880192261 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.2666907689912.

 Limitations

  • The company has shown a poor profit growth of 7.43369885145775% for the Past 3 years.
  • The company is trading at a high PE of 78.58.
  • The company is trading at a high EV/EBITDA of 36.2046.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 264.56 264.41 256.29 285.46 269.41
Total Expenditure 199.05 196.69 198.03 217.98 210.58
Operating Profit 65.5 67.72 58.26 67.47 58.83
Other Income 6.79 9.14 2.78 2.01 5.19
Interest 5.97 6.3 5.83 5.62 5.24
Depreciation 21.95 22.23 19.99 21.37 24.14
Exceptional Items 0 0 0 0 0
Profit Before Tax 44.38 48.32 35.23 42.49 34.63
Tax 11.55 8.39 9.1 11.21 7.93
Profit After Tax 32.83 39.93 26.13 31.28 26.7
Adjusted EPS (Rs) 6.41 7.8 5.1 6.11 5.21

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 581.21 665.31 961.39 1157.01 1066.04
Total Expenditure 433.74 489.25 676.52 832.71 794.56
Operating Profit 147.47 176.05 284.87 324.3 271.48
Other Income 20.52 29.32 12.31 16.15 23.72
Interest 3.37 10.01 11.26 24.54 31.29
Depreciation 15.44 30.85 43.78 60.26 84.96
Exceptional Items 0 -24.53 0 15.9 0
Profit Before Tax 149.19 139.99 242.13 271.55 178.95
Tax 47.73 27.94 59.48 72.01 40
Net Profit 101.46 112.05 182.65 199.53 138.95
Adjusted EPS (Rs.) 20.22 22.13 35.73 38.99 27.13

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 10.04 10.13 10.22 10.23 10.24
Total Reserves 405.37 502.26 654.59 828.97 925.77
Borrowings 0 0 0 158.68 30.77
Other N/C liabilities 141.21 166.3 113.78 333.26 386.48
Current liabilities 183.12 153.67 222.04 347.89 290.5
Total Liabilities 739.74 832.35 1000.63 1679.03 1643.78
Assets
Net Block 162.9 215.78 307.09 1004.73 1065.77
Capital WIP 0 0 0 0 0
Intangible WIP 5.77 2.99 0 5.78 19.51
Investments 131.73 129.78 3.54 36.65 36.65
Loans & Advances 141.9 150.06 67.29 201.44 217.97
Other N/C Assets 11.08 11.67 1.64 16.28 1.21
Current Assets 286.36 322.08 621.06 414.15 302.67
Total Assets 739.74 832.35 1000.63 1679.03 1643.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 149.19 139.99 242.13 271.55 178.95
Adjustment 3.8 49.41 71.33 54.34 96.11
Changes in Assets & Liabilities -44.83 14.34 -22.16 -5.67 6.72
Tax Paid -51.74 -47.61 -55.06 -76.17 -44.04
Operating Cash Flow 56.43 156.13 236.23 244.04 237.74
Investing Cash Flow -4.35 -51.13 59.42 -736.21 46.72
Financing Cash Flow -63.97 -46.37 -31.27 171.97 -287.87
Net Cash Flow -11.89 58.63 264.38 -320.19 -3.4

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 49.75 49.75 49.74 49.74 49.67
ameera sushil shah 0.36 0.36 0.36 0.36 0.35
duru shah family trust 9.69 - 9.69 9.69 9.69
duru sushil shah 1.50 11.19 1.49 1.49 1.49
metz advisory llp 30.64 30.64 30.63 30.63 30.63
sushil kanubhai shah 2.57 7.57 2.57 2.57 2.50
sushil shah family trust 5.00 - 4.99 4.99 4.99
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 50.25 50.25 50.26 50.26 50.33
aditya birla sun life tru... 2.72 1.73 1.38 1.33 1.18
caisse de depot et placem... - - 1.39 1.58 1.44
franklin india smaller co... 1.23 1.56 1.98 2.04 2.99
fssa indian subcontinent ... - - - 1.03 1.14
hdfc mutual fund - hdfc f... - - - - 6.65
j p morgan funds 2.83 2.80 2.67 2.53 2.22
jpmorgan indian investmen... 1.39 1.39 1.39 1.39 1.39
llp 0.12 0.12 0.11 0.09 0.03
nippon life india trustee... - - - - 2.56
quant mutual fund - quant... - - - - 1.86
sbi life insurance co. lt... - - - 1.63 2.14
the scottish oriental sma... - 1.19 1.19 1.19 1.19
uti large cap fund - - - - 5.45
nippon life india trustee... - - - 2.56 -
tata aia life insurance c... - - - 1.48 -
uti flexi cap fund - 6.82 6.77 6.57 -
tata aia life insurance c... - - 1.02 - -
caisse de depot et placem... 1.28 1.32 - - -
grandeur peak internation... 1.26 1.11 - - -
uti felxi cap fund 6.99 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Metropolis Healthcare informs about conference call16 May 2024, 10:18AM Metropolis Healthcare informs about board meeting 14 May 2024, 9:45AM Metropolis Healthcare informs about disclosure 30 Apr 2024, 4:54PM Metropolis Healthcare reports 15% growth in core business revenue during Q4FY2412 Apr 2024, 11:53AM Metropolis Healthcare informs about disclosure14 Mar 2024, 10:42AM Metropolis Healthcare informs about disclosure5 Mar 2024, 5:16PM Metropolis Healthcare informs about disclosure29 Feb 2024, 5:13PM Metropolis Health. - Quaterly Results2 Feb 2024, 6:28PM Metropolis Health. - Quaterly Results2 Feb 2024, 6:28PM Metropolis Healthcare informs about board meeting27 Jan 2024, 11:00AM Metropolis Healthcare informs about clarification on media reports15 Jan 2024, 9:58AM Metropolis Health. - Quaterly Results4 Nov 2023, 6:54PM Metropolis Health. - Quaterly Results4 Nov 2023, 6:54PM Metropolis Health. - Quaterly Results4 Nov 2023, 6:54PM Metropolis Healthcare submits intimation of grant of restrictive stock units 4 Nov 2023, 2:19PM Metropolis Healthcare informs about certificate12 Oct 2023, 4:59PM Metropolis Healthcare informs about analyst meet23 Sep 2023, 12:46PM Metropolis Healthcare submits disclosure 29 Aug 2023, 11:18AM Metropolis Healthcare informs about disclosure28 Aug 2023, 2:30PM Metropolis Healthcare informs about transcript of conference call9 Aug 2023, 5:00PM Metropolis Health. - Quaterly Results2 Aug 2023, 6:12AM Metropolis Health. - Quaterly Results2 Aug 2023, 6:12AM Metropolis Healthcare informs about BRSR 25 Jul 2023, 9:38AM Metropolis Healthcare informs about AGM and annual Report 25 Jul 2023, 9:38AM Metropolis Healthcare reports 17% fall in Q4 consolidated net profit17 May 2023, 11:30AM Metropolis Healthcare informs about disclosure of related party transactions17 May 2023, 9:46AM Metropolis Health. - Quaterly Results16 May 2023, 6:34PM Metropolis Health. - Quaterly Results16 May 2023, 6:34PM Metropolis Health. - Quaterly Results16 May 2023, 6:34PM Metropolis Healthcare informs about disclosure 4 Apr 2023, 10:33AM Metropolis Healthcare informs about earnings call transcript18 Feb 2023, 11:01AM Metropolis Health. - Quaterly Results10 Feb 2023, 4:46PM Metropolis Health. - Quaterly Results10 Feb 2023, 4:46PM Metropolis Health. - Quaterly Results10 Feb 2023, 4:46PM Metropolis Healthcare informs about press release 9 Dec 2022, 12:48PM Metropolis Healthcare informs about disclosure 1 Dec 2022, 11:07AM Metropolis Healthcare informs about disclosure 1 Dec 2022, 11:06AM Metropolis Health. - Quaterly Results8 Nov 2022, 4:43PM Metropolis Health. - Quaterly Results8 Nov 2022, 4:43PM Metropolis Health. - Quaterly Results8 Nov 2022, 4:43PM Metropolis Healthcare informs about conference call1 Nov 2022, 11:41AM Metropolis Health. - Quaterly Results10 Aug 2022, 4:45PM Metropolis Health. - Quaterly Results10 Aug 2022, 4:45PM Metropolis Health. - Quaterly Results10 Aug 2022, 4:45PM Metropolis Healthcare informs about annual report27 Jul 2022, 12:55PM Metropolis Healthcare informs about certificate6 Jul 2022, 4:16PM Metropolis Healthcare informs about analyst meet intimation17 Jun 2022, 4:16PM Metropolis Health. - Quaterly Results24 May 2022, 6:34PM Metropolis Health. - Quaterly Results24 May 2022, 6:34PM Metropolis Healthcare informs about disclosure28 Feb 2022, 3:24PM

Metropolis Health. Stock Price Analysis and Quick Research Report. Is Metropolis Health. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Metropolis Health. and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Metropolis Health. cash from the operating activity was Rs 237.7385 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Metropolis Health. has a Debt to Equity ratio of 0.0886 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Metropolis Health. , the EPS growth was -30.416384563304 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Metropolis Health. has OPM of 25.4660070670848 % which is a good sign for profitability.
     
  • ROE: Metropolis Health. have a average ROE of 15.8247127593682 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Metropolis Health. is Rs 1874.15. One can use valuation calculators of ticker to know if Metropolis Health. share price is undervalued or overvalued.
Last Updated on:
Brief about Metropolis Health.

Metropolis Healthcare Ltd. Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis

Metropolis Healthcare Ltd. is a leading provider of diagnostic services founded in 1981. As a long-term stock investor, evaluating the company's financial performance through stock analysis is essential to determine its potential investment opportunities. Our Metropolis Healthcare Ltd., stock analysis page, provides in-depth analysis and reliable information on critical areas such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Metropolis Healthcare Ltd. Share Price:

An analysis of Metropolis Healthcare Ltd.'s share price performance is crucial for long-term investors seeking the best stock analysis options. The company's share price trends over time need to be analyzed for its performance. Our pre-built screening tool enables investors to compare and analyze the company's stock price with its industry peers, making it easier to identify potential investment opportunities. Investors can evaluate the company's performance over the long term, comparing trends and analyzing financial ratios to identify potential opportunities. A stock's share price is determined by a range of factors, such as market sentiment, financial performance, and general economic conditions.

Metropolis Healthcare Ltd. Balance Sheet:

Metropolis Healthcare Ltd. is a growing company with great potential for long-term investment. Analyzing the company's balance sheet is an important indicator of the company's financial health and growth potential. Our screening tool allows investors to evaluate the company's liquidity, debt levels, and relevant ratios, such as the current ratio and quick ratio. The tool also compares the company's balance sheet with industry peers, making it easier for investors to identify potential investment opportunities.

Metropolis Healthcare Ltd. Annual Report:

A thorough analysis of Metropolis Healthcare Ltd.'s annual report enables investors to gain valuable insights into the company's financial performance and strategic initiatives as a long-term investment opportunity. Our analysis page provides investors with access to the company's financial reports as downloadable documents. Furthermore, our premium feature tools, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont Analysis, provide a comprehensive evaluation of the company's performance and growth potential. Using these tools, investors can conduct a thorough analysis, unlocking valuable insights to inform investment decisions.

Metropolis Healthcare Ltd. Dividend:

Dividend payout history and consistency of Metropolis Healthcare Ltd. is vital for long-term investors seeking stable investment returns. Our stock analysis page provides information on the company's dividend payout history, and our screening tool helps investors analyze its long-term performance and growth potential. Our screening tool also enables investors to evaluate dividend payout trends compared to industry peers, making it easier to identify potential investment opportunities.

Metropolis Healthcare Ltd. Quarterly Result:

Analyzing the company's quarterly results is crucial to determine the company's financial performance and growth potential as a long-term investment opportunity. Our analysis page provides investors with access to the company's quarterly results as downloadable documents. The premium feature tools such as DCF Analysis and Earnings Multiple Approach enable investors to analyze the information provided in the transcripts more comprehensively than otherwise possible.

Metropolis Healthcare Ltd. Stock Price:

Metropolis Healthcare Ltd.'s stock price performance is a crucial factor for investors seeking the best stock analysis options. Our analysis page provides real-time information on the company's stock price trends, enabling investors to evaluate its performance over time. Our screening tool also enables investors to compare the company's share price performance with industry peers, making it easier to identify potential investment opportunities. Our website provides pre-built screening tools to help investors analyze stock prices and performance.

Metropolis Healthcare Ltd. Price Chart:

Our analysis page offers a price chart that visualizes Metropolis Healthcare Ltd.'s stock price trends over time to provide valuable insight into potential investment opportunities. Our screening tool enables investors to evaluate the company's performance over the long term, comparing trends to make informed investment decisions. Investors can evaluate trends and compare Metropolis Healthcare Ltd.’s share price performance with industry peers, assisting them in identifying potential investment opportunities.

Metropolis Healthcare Ltd. News:

Keeping up-to-date with the latest news and developments about Metropolis Healthcare Ltd. is crucial for long-term investors. Our stock analysis page provides timely news articles about the company, enabling investors to stay informed about the company's financial performance and other relevant events that may impact growth potential. By tracking both local and international news, investors gain valuable insights into the company's market performance and potential as a long-term investment opportunity.

Metropolis Healthcare Ltd. Concall Transcripts:

Analyzing Metropolis Healthcare Ltd.'s concall transcripts provides investors with valuable insights into the company's future guidance, strategic initiatives, and financial performance. Our analysis page offers investors access to the company's concall transcripts as downloadable documents, enabling them to make informed investment decisions. The premium feature tools like DCF Analysis and Earnings Multiple Approach help investors analyze the information provided in the transcripts comprehensively.

Metropolis Healthcare Ltd. Investor Presentation:

Metropolis Healthcare Ltd.'s investor presentations provide valuable insights into the company's growth potential as a long-term investment opportunity. Our analysis page offers investors access to the company's investor presentations as downloadable documents, enabling them to analyze the information more comprehensively. The premium feature tools like BVPS Analysis and DuPont Analysis aid investors in evaluating the company's performance and making informed investment decisions.

Metropolis Healthcare Ltd. Promoter and Shareholder Analysis:

Investors require a deep understanding of Metropolis Healthcare Ltd.'s promoters and shareholders to determine the company's potential as a long-term investment opportunity. Ticker analysis page provides information on the company's promoters and shareholders, enabling investors to make informed decisions about their investments. Furthermore, our screening tool analyzes the company's shareholding patterns and provides valuable insights into the company's potential for growth.

Read More
X